EU agency to review safety of newer contraceptive pills

LONDON Mon Jan 28, 2013 10:38pm IST

An illustration picture shows a woman holding a birth control pill at her home in Nice January 3, 2013. REUTERS/Eric Gaillard

An illustration picture shows a woman holding a birth control pill at her home in Nice January 3, 2013.

Credit: Reuters/Eric Gaillard

Related Topics

Stocks

   

LONDON (Reuters) - The European Medicines Agency is to review the safety of third and fourth-generation combined oral contraceptives to decide if there is a need to restrict their use.

Monday's move followed a request by France, where authorities have already taken steps to reduce use of the drugs in favour of second-generation birth control pills.

The newer pills, which include Bayer's (BAYGn.DE) Meliane or Yasmin, have proved popular because they reduce side effects seen with earlier versions, such as weight gain and acne.

But France wants the European Union regulator to restrict their use because of concerns they carry a higher risk of dangerous blood clots.

While all oral contraceptives are associated with some danger of blood clots, a number of studies suggest the most recent third- and fourth-generation pills carry a higher risk than their predecessors.

The London-based European Medicines Agency (EMA), which said earlier this month there was no new evidence of safety risks, said the blood-clot risk with all birth control pills was "very small", although it was higher for third- and fourth-generation ones.

"There is no reason for any woman to stop taking her contraceptive. If a woman has concerns, she can discuss this with her doctor," the EMA said in its latest statement.

The French government earlier this month said it would stop reimbursing prescription costs of the third- and fourth-generation pills and would restrict their use after a woman sued Bayer over alleged side effects.

About 2.5 million women in France take third- and fourth-generation pills, roughly half all those on oral contraceptives. French health authorities argue this use of the newer pills is excessive.

(Reporting by Ben Hirschler; Editing by Anthony Barker)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Gaza Attack

Gaza Attack

At least 15 killed by shelling of Gaza school; toll exceeds 760  Full Article 

Ukraine PM Resigns

Ukraine PM Resigns

Ukrainian prime minister tenders his resignation in parliament.  Full Article 

Health Crisis

Health Crisis

Myanmar Muslims in remote Rakhine suffer worsening health crisis.  Full Article 

Afghan Election

Afghan Election

Afghan vote recount moves at snail's pace, rival sides far apart.  Full Article 

Iraq Government

Iraq Government

Iraq elects president as Ban urges unity to save nation.  Full Article 

Sanctions Plan

Sanctions Plan

EU targets state-owned Russia banks  Full Article 

MH17 Crash

MH17 Crash

Investigators find no evidence of MH17 black box tampering  Full Article 

Special Report

Special Report

Inside Xi Jinping's purge of China's oil mandarins  Full Article 

Freedom at Last

Freedom at Last

Death row Christian woman flies out of Sudan, meets Pope.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage